Alternative splicing in breast cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Alternative splicing of pre-mRNA is an essential event that leads to protein diversity and regulation of the cellular processes in mammals. With the advent of the next generation sequencing technologies, the role of alternative splicing is gaining a momentum. Regulation of alternative splicing is a complex process involving the core spliceosome machinery and multiple regulatory factors that enable the tightly controlled splicing of introns/exons. Any aberrant alteration in this process can result in diseases such as cancer. Indeed, accumulating evidence suggests that alternative splicing plays an important role in all hallmarks of cancer including proliferative signaling, resisting cell death, inducing angiogenesis, and activating invasion and metastasis. These changes may occur due to mutations or altered expression levels of key regulatory genes of spliceosome machinery or splicing factors. In this review, we summarize recent findings that have implicated the critical role of alternative splicing in breast cancer and discuss current understandings and its potential utility in breast cancer.

Original languageEnglish (US)
Title of host publicationMolecular Pathology of Breast Cancer
PublisherSpringer International Publishing
Pages365-377
Number of pages13
ISBN (Electronic)9783319417615
ISBN (Print)9783319417592
DOIs
StatePublished - Jan 1 2016

Fingerprint

Alternative Splicing
Breast Neoplasms
Spliceosomes
RNA Precursors
Regulator Genes
Introns
Mammals
Exons
Neoplasms
Cell Death
Neoplasm Metastasis
Technology
Mutation
Proteins

Keywords

  • Alternative splicing
  • Alternative splicing events
  • Breast cancer
  • Spliceosome machinery
  • Splicing factors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Polar, Y. (2016). Alternative splicing in breast cancer. In Molecular Pathology of Breast Cancer (pp. 365-377). Springer International Publishing. https://doi.org/10.1007/978-3-319-41761-5_23

Alternative splicing in breast cancer. / Polar, Yesim.

Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. p. 365-377.

Research output: Chapter in Book/Report/Conference proceedingChapter

Polar, Y 2016, Alternative splicing in breast cancer. in Molecular Pathology of Breast Cancer. Springer International Publishing, pp. 365-377. https://doi.org/10.1007/978-3-319-41761-5_23
Polar Y. Alternative splicing in breast cancer. In Molecular Pathology of Breast Cancer. Springer International Publishing. 2016. p. 365-377 https://doi.org/10.1007/978-3-319-41761-5_23
Polar, Yesim. / Alternative splicing in breast cancer. Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. pp. 365-377
@inbook{8d72542b61504935809e1abbbe6feb4b,
title = "Alternative splicing in breast cancer",
abstract = "Alternative splicing of pre-mRNA is an essential event that leads to protein diversity and regulation of the cellular processes in mammals. With the advent of the next generation sequencing technologies, the role of alternative splicing is gaining a momentum. Regulation of alternative splicing is a complex process involving the core spliceosome machinery and multiple regulatory factors that enable the tightly controlled splicing of introns/exons. Any aberrant alteration in this process can result in diseases such as cancer. Indeed, accumulating evidence suggests that alternative splicing plays an important role in all hallmarks of cancer including proliferative signaling, resisting cell death, inducing angiogenesis, and activating invasion and metastasis. These changes may occur due to mutations or altered expression levels of key regulatory genes of spliceosome machinery or splicing factors. In this review, we summarize recent findings that have implicated the critical role of alternative splicing in breast cancer and discuss current understandings and its potential utility in breast cancer.",
keywords = "Alternative splicing, Alternative splicing events, Breast cancer, Spliceosome machinery, Splicing factors",
author = "Yesim Polar",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-41761-5_23",
language = "English (US)",
isbn = "9783319417592",
pages = "365--377",
booktitle = "Molecular Pathology of Breast Cancer",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Alternative splicing in breast cancer

AU - Polar, Yesim

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Alternative splicing of pre-mRNA is an essential event that leads to protein diversity and regulation of the cellular processes in mammals. With the advent of the next generation sequencing technologies, the role of alternative splicing is gaining a momentum. Regulation of alternative splicing is a complex process involving the core spliceosome machinery and multiple regulatory factors that enable the tightly controlled splicing of introns/exons. Any aberrant alteration in this process can result in diseases such as cancer. Indeed, accumulating evidence suggests that alternative splicing plays an important role in all hallmarks of cancer including proliferative signaling, resisting cell death, inducing angiogenesis, and activating invasion and metastasis. These changes may occur due to mutations or altered expression levels of key regulatory genes of spliceosome machinery or splicing factors. In this review, we summarize recent findings that have implicated the critical role of alternative splicing in breast cancer and discuss current understandings and its potential utility in breast cancer.

AB - Alternative splicing of pre-mRNA is an essential event that leads to protein diversity and regulation of the cellular processes in mammals. With the advent of the next generation sequencing technologies, the role of alternative splicing is gaining a momentum. Regulation of alternative splicing is a complex process involving the core spliceosome machinery and multiple regulatory factors that enable the tightly controlled splicing of introns/exons. Any aberrant alteration in this process can result in diseases such as cancer. Indeed, accumulating evidence suggests that alternative splicing plays an important role in all hallmarks of cancer including proliferative signaling, resisting cell death, inducing angiogenesis, and activating invasion and metastasis. These changes may occur due to mutations or altered expression levels of key regulatory genes of spliceosome machinery or splicing factors. In this review, we summarize recent findings that have implicated the critical role of alternative splicing in breast cancer and discuss current understandings and its potential utility in breast cancer.

KW - Alternative splicing

KW - Alternative splicing events

KW - Breast cancer

KW - Spliceosome machinery

KW - Splicing factors

UR - http://www.scopus.com/inward/record.url?scp=85009675183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009675183&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-41761-5_23

DO - 10.1007/978-3-319-41761-5_23

M3 - Chapter

SN - 9783319417592

SP - 365

EP - 377

BT - Molecular Pathology of Breast Cancer

PB - Springer International Publishing

ER -